Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Evans

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Journal of Minimally Invasive Gynecology|November 5, 2013
Reliability of visual diagnosis of endometriosisShavi Fernando, Pei Qian Soh, Michael Cooper, et al.
Clinical Chemistry|February 15, 2023
A Spotlight on Disruptors and InnovatorsKhushbu Patel, Susan Evans, Jong Lee, et al.
International Wound Journal|February 7, 2020
Pressure injury data in Australian acute care settings: A comparison of three data setsVictoria Team, Michelle Tuck, Judy Reeves, et al.
European Urology|July 7, 2015
The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate CancerGiacomo Canesin, Susan Evans-Axelsson, Rebecka Hellsten, et al.
Journal of Clinical Psychology|August 8, 2014
Sleep disturbance, disability, and posttraumatic stress disorder in utility workersCezar Giosan, Loretta S Malta, Katarzyna Wyka, et al.
Marine Environmental Research|August 28, 2025
Mechanical properties and elemental composition of the beak in selected cephalopod species: patterns and variabilityAnastasiia Maliuk, Dominik Dziedzic, Arsalan Marghoub, et al.
Journal of Medicinal Chemistry|April 26, 2016
Preclinical Characterization of 3β-(N-Acetyl l-cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate CancerZilma Escobar, Anders Bjartell, Giacomo Canesin, et al.
Plos One|September 9, 2017
Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse modelGiacomo Canesin, Susan Evans-Axelsson, Rebecka Hellsten, et al.
American Journal of Nuclear Medicine and Molecular Imaging|April 23, 2014
Multi-radionuclide digital autoradiography of the intra-aortic atherosclerotic plaques using a monoclonal antibody targeting oxidized low-density lipoproteinAnders Orbom, Bo Jansson, Alexandru Schiopu, et al.
Trauma Surgery & Acute Care Open|May 7, 2019
AAST Critical Care Committee clinical consensus: ECMO, nutritionDavid Zonies, Panna Codner, Pauline Park, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Journal of Minimally Invasive Gynecology|November 5, 2013
Reliability of visual diagnosis of endometriosisShavi Fernando, Pei Qian Soh, Michael Cooper, et al.
Clinical Chemistry|February 15, 2023
A Spotlight on Disruptors and InnovatorsKhushbu Patel, Susan Evans, Jong Lee, et al.
International Wound Journal|February 7, 2020
Pressure injury data in Australian acute care settings: A comparison of three data setsVictoria Team, Michelle Tuck, Judy Reeves, et al.
European Urology|July 7, 2015
The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate CancerGiacomo Canesin, Susan Evans-Axelsson, Rebecka Hellsten, et al.
Journal of Clinical Psychology|August 8, 2014
Sleep disturbance, disability, and posttraumatic stress disorder in utility workersCezar Giosan, Loretta S Malta, Katarzyna Wyka, et al.
Marine Environmental Research|August 28, 2025
Mechanical properties and elemental composition of the beak in selected cephalopod species: patterns and variabilityAnastasiia Maliuk, Dominik Dziedzic, Arsalan Marghoub, et al.
Journal of Medicinal Chemistry|April 26, 2016
Preclinical Characterization of 3β-(N-Acetyl l-cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate CancerZilma Escobar, Anders Bjartell, Giacomo Canesin, et al.
Plos One|September 9, 2017
Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse modelGiacomo Canesin, Susan Evans-Axelsson, Rebecka Hellsten, et al.
American Journal of Nuclear Medicine and Molecular Imaging|April 23, 2014
Multi-radionuclide digital autoradiography of the intra-aortic atherosclerotic plaques using a monoclonal antibody targeting oxidized low-density lipoproteinAnders Orbom, Bo Jansson, Alexandru Schiopu, et al.
Trauma Surgery & Acute Care Open|May 7, 2019
AAST Critical Care Committee clinical consensus: ECMO, nutritionDavid Zonies, Panna Codner, Pauline Park, et al.
Pageof 10